White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorImperial College London

About this trial

Idiopathic Normal Pressure Hydrocephalus (iNPH) is a progressive condition of the elderly that results in severe disability. iNPH can dramatically respond to Cerebral spinal fluid(CSF)-shunting where excess ventricular fluid is diverted from the brain. Not all patients with iNPH respond to CSF-shunting however. The reasons for this are uncertain.

Aim 1: To understand if specific nerve pathways (white matter tracts) that are near ventricles are damaged in patients that respond to shunting as opposed to those that do not.

Aim 2: Can we explain shunt non-responsiveness by screening for dementia like illnesses (neurodegeneration) using a large array of methods.

Aim 3: To understand whether wearable activity and bed sleep monitors are palatable in a NPH population and to understand if these metrics relate to quality of life.

Aim 4: To see whether self-administered digital cognitive assessments can measure improvements pre and post surgery.

Eligibility criteria

Qualifiers

Adult patients >60

With gait apraxia

With or without cognitive impairment

Urinary dysfunction

Disqualifiers

Asymptomatic hydrocephalus

High pressure-hydrocephalus

Serious head injury within 5 years of presentation or a clear secondary cause (e.g. brain infection)

History of childhood gait disturbance

Trial design

Treatments tested in this trial

  • Ventriculoperitoneal Shunt (VP)
  • Brain and Skin Biopsy
  • MRI Brain

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Imperial College London

Lead sponsor

Medical Research Council

Collaborator

Michael J. Fox Foundation for Parkinson's Research

Collaborator

University College, London

Collaborator

University of Edinburgh

Collaborator

King's College London

Collaborator